XBI trailing returns
SPDR S&P Biotech ETF's 10-year annualized return is +11.3% per year (+191.4% cumulative). How SPDR S&P Biotech ETF (XBI) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through July 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-07-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +2.5% | |
| 1 week | — | +5.9% | |
| 1 month | — | +25.6% | |
| YTD | — | +31.6% | |
| 1 year | +93.8% | +93.8% | |
| 5 years | +3.1% | +16.5% | |
| 10 years | +11.3% | +191.4% | |
| 20 years | +12.8% | +1008.1% | |
| Since inception (2006) | +12.1% | +932.5% |
Growth of XBI#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-07-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from XBI's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ
- What is SPDR S&P Biotech ETF's 10-year return?
- Over the last 10 years, SPDR S&P Biotech ETF (XBI) returned about +11.3% a year annualized (+191.4% cumulative total return).
- What is SPDR S&P Biotech ETF's 20-year annualized return?
- Over the last 20 years, SPDR S&P Biotech ETF (XBI) compounded at about +12.8% a year (+1008.1% cumulative).
- What is SPDR S&P Biotech ETF's return since inception?
- Since 2006, SPDR S&P Biotech ETF (XBI) has compounded at about +12.1% a year — +932.5% in total.